Group 1 - The North Exchange 50 index increased by 5.82%, with average daily trading volume rising by 34.58% [4][12] - The strongest sectors this week included military, TMT, and pharmaceuticals, with the commercial aerospace sector showing significant strength [7][8] - Notable stock performances included Tianli Composite (+35.97%), Huitong New Materials (+23.77%), and Beikang (+45.1%) [4][7] Group 2 - The North Exchange's strong stock ratio increased to 38.7%, indicating potential for continued market momentum [7][11] - The report highlights a shift in market style from small-cap stocks to growth sectors, particularly in AI computing and other emerging technologies [7][8] - The report emphasizes the importance of timing in thematic investments, particularly in the context of the upcoming "14th Five-Year Plan" [7][8] Group 3 - The report identifies key sectors to watch in the upcoming week, including the space photovoltaic industry and AI applications [8] - Specific companies of interest include Liancheng Numerical Control, Optech, and Deepseek V4, among others [8] - The report anticipates a return of absolute return funds in early 2026, with a focus on undervalued stocks [8] Group 4 - The North Exchange had 287 companies listed as of January 9, 2026, with new listings and approvals ongoing [24][28] - This week, five new companies were listed, and five were delisted, with a total planned financing of 221 million yuan [42][44] - The report notes that the North Exchange's PE (TTM) median is 42.05 times, reflecting a positive trend in valuations [12][19]

Market Performance - The North Exchange 50 Index increased by 5.82% compared to the previous week, while the Shanghai and Shenzhen 300 Index rose by 2.79% and the ChiNext Index by 3.89%[30] - The average market capitalization of North Exchange A-shares reached 3.197 billion yuan, with a daily average trading volume of approximately 26.13 billion yuan, up 34.57% from the previous week[5] Investment Recommendations - Focus on sectors with high industry prosperity and scarcity, particularly commercial aerospace, robotics, low-altitude economy, energy storage, solid-state batteries, and liquid cooling[40] - The PE ratios for North Exchange A-shares, ChiNext, Shanghai Main Board, Shenzhen Main Board, and Sci-Tech Innovation Board are 48.40, 45.54, 12.69, 24.07, and 78.26 respectively as of January 9, 2026[40] Economic Indicators - The Consumer Price Index (CPI) rose by 0.8% year-on-year in December 2025, marking the highest increase since March 2023[22] - The Producer Price Index (PPI) increased by 0.2% month-on-month in December 2025, but decreased by 1.9% year-on-year[22] Regulatory Developments - The People's Bank of China is expected to implement a prudent monetary policy, emphasizing the need for financial support for economic stability and growth in 2026[11] - The China Securities Regulatory Commission is intensifying efforts to combat financial fraud in the capital market, with 159 cases of financial fraud handled in 2024[18] Industry News - China applied for frequency resources for over 200,000 satellites in December 2025, indicating a significant expansion in the commercial aerospace sector[29] - The United Nations projects global economic growth at 2.7% for 2026, slightly lower than the 2.8% estimated for 2025, amid ongoing macroeconomic uncertainties[26]

Summary of Key Points Core Viewpoint - The trading volume and value of stocks on the Beijing Stock Exchange (BSE) saw a significant increase on January 9, with a total trading volume of 1.14 billion shares and a trading value of 29.886 billion yuan, marking an increase of 3.682 billion yuan compared to the previous trading day [1]. Trading Performance - A total of 202 stocks closed higher, representing 70.38% of the tradable stocks on the BSE, with notable gainers including Ge Li Er and Zhong Cheng Technology, which hit the daily limit up [1]. - The top gainers included Fuji Da, Hai Neng Technology, and Xing Tu Ce Kong, with increases of 9.47%, 7.95%, and 7.81% respectively [1]. - Conversely, 77 stocks closed lower, with Bei Yi Kang, Kai De Quartz, and Tian Li Composite showing the largest declines of 11.47%, 7.23%, and 6.18% respectively [1]. Trading Activity - There were 84 stocks with a trading value exceeding 10 million yuan, with Tian Li Composite, Fuji Da, and Xing Tu Ce Kong leading in trading value at 1.128 billion yuan, 1.051 billion yuan, and 1.037 billion yuan respectively [1]. - The trading activity was robust, with 44 stocks having a turnover rate exceeding 10%, and 10 stocks exceeding 20% [1]. Notable Stocks - The stock with the highest turnover rate was Zhong Cheng Technology at 35.49%, followed by Tian Run Technology at 28.04% and Da Peng Industrial at 27.70% [1]. - The trading details of several notable stocks were provided, highlighting their closing prices, percentage changes, turnover rates, and trading values [1][2][3][4][5][6][7][8][9][10].

Core Viewpoint - The stock of BeiYikang (920199) experienced a rise of 1.80% with a turnover rate of 27.17%, indicating significant trading activity and interest from institutional investors [2] Trading Activity - The total trading volume for BeiYikang reached 5.79 billion yuan, with a price fluctuation of 17.39% throughout the day [2] - Institutional investors net bought 3.43 million yuan, while brokerage seats collectively net sold 30.22 million yuan [2] - The stock was listed on the daily trading board due to its turnover rate of 27.17% [2] Institutional Participation - Among the top five trading departments, the total transaction volume was 128 million yuan, with a buying amount of 50.65 million yuan and a selling amount of 77.45 million yuan, resulting in a net sell of 26.79 million yuan [2] - One institutional seat was noted in the trading data, with a net buy of 3.43 million yuan, buying 8.68 million yuan and selling 5.25 million yuan [2] Historical Performance - Over the past six months, BeiYikang has appeared on the trading board nine times, with an average price increase of 4.03% the day after being listed and an average increase of 1.04% over the following five days [2]

Group 1 - The report highlights the significant progress in the pharmaceutical and healthcare system reforms during the "14th Five-Year Plan" period, with a focus on grassroots healthcare and urban-rural integration [1][12] - The "15th Five-Year Plan" emphasizes the support for innovative drugs and medical devices, aiming to enhance the healthcare system and promote the development of traditional Chinese medicine [1][17] - The report indicates that the 11th batch of national drug procurement successfully implemented innovative goals, including maintaining clinical stability and quality assurance [1][14] Group 2 - As of December 31, 2025, the total market capitalization of 21 pharmaceutical and biotechnology companies on the North Exchange reached 748.30 billion, reflecting a growth of 45.81% from the beginning of the year [2][20] - The average market capitalization of these companies increased to 35.63 billion, up 38.87% from the previous year [2][21] - The North Exchange's pharmaceutical sector is primarily composed of chemical pharmaceuticals (38.10%), medical devices (28.57%), and biological products (19.05%) [2][31] Group 3 - In 2025, the North Exchange's pharmaceutical and biotechnology sector experienced a year-on-year increase of 37.38%, ranking third among various sectors [3][54] - The report notes that 80.95% of the pharmaceutical companies on the North Exchange saw an increase in their stock prices throughout the year [3][42] - The top-performing companies in terms of stock price growth included JinHao Medical (+174.08%), NuoSiLanDe (+105.64%), and BeiYiKang (+76.39%) [3][45] Group 4 - The report indicates that the North Exchange's pharmaceutical companies had a PE TTM average of 73X by the end of 2025, with a peak of 119X in August [2][34] - The distribution of valuations shows that the North Exchange has a higher proportion of companies with significant losses compared to other exchanges, with 28.57% of companies in the loss category [2][40] - The report highlights that the North Exchange's pharmaceutical sector is characterized by a high concentration of companies in the 100X and above PE TTM range [2][43]

Group 1 - The core point of the news is that Beiyikang (stock code: 920199) was listed on the Longhu list on January 7, 2026, due to a significant trading activity, with a turnover rate of 33.29% and a transaction volume of 12.302 million shares, amounting to 752 million yuan [1][2][3] Group 2 - The top buying seat was from Guotai Junan Securities Co., Ltd., Shanghai Sipin Road branch, with a purchase amount of approximately 14.82 million yuan [2] - The top selling seat was from China Galaxy Securities Co., Ltd., Xingtai Metallurgical North Road branch, with a selling amount of approximately 30.26 million yuan [2] - Other notable buying and selling activities included multiple branches of Dongfang Caifu Securities and CITIC Jiantou Securities, indicating a diverse trading interest in Beiyikang [2]

Core Insights - The North Exchange 50 index increased by 1.82% to close at 1,493.04 points on January 6, 2026, with a trading volume of 259.89 billion yuan and a turnover rate of 3.97% [3][4][6] - The overall valuation of the North Exchange is at 47.74 times earnings, which is higher than the valuations of the ChiNext and STAR Market [3][10] - The sectors that performed well include non-ferrous metals (+11.1%), home appliances (+4.5%), computers (+4.4%), and machinery (+3.0%), while the pharmaceutical sector saw a decline of 0.5% [3][4] Trading Performance - On January 6, 2026, the North Exchange had a total market capitalization of 903.76 billion yuan, with 396.77 billion shares listed, of which 253.49 billion shares were tradable [3][4] - The average daily trading volume for the previous week was 194.04 billion yuan, indicating a recovery in trading levels on January 6 [3][4] Stock Performance - Among the 287 listed companies, 264 saw an increase in stock prices, while 21 experienced declines. Notable gainers included Hanxin Technology (+29.99%) and Tianli Composite (+29.99%), while Jin Hao Medical saw a significant drop of 14.57% [3][8][9] - The top ten stocks by market performance on January 6 included Hanxin Technology, Tianli Composite, and Beiyikang, with respective market capitalizations of 30.35 billion yuan, 95.63 billion yuan, and 39.80 billion yuan [8][9] Valuation Analysis - The average price-to-earnings (P/E) ratio for companies on the North Exchange is 47.74 times, with the highest sector being non-ferrous metals at 126.1 times, followed by home appliances at 92.8 times and food and beverage at 81.7 times [3][10] - The valuation of the North Exchange continues to be higher than that of the ChiNext, which has a P/E ratio of 44.85 times [3][10] Sector Performance - The non-ferrous metals sector showed the highest increase in stock prices, reflecting strong market interest and potential growth opportunities [3][4] - The pharmaceutical sector, in contrast, faced challenges, as indicated by the decline in stock prices, suggesting potential issues within the industry [3][4][9]

四川千里倍益康医疗科技股份有限公司股票交易异常波动公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带法律责任。 证券代码：920199 证券简称:倍益康 公告编号：2026-001 三、是否存在应披露而未披露的重大信息的声明 本公司董事会确认，本公司没有任何根据《北京证券交易所股票上市规则》 等有关规定应披露而未披露的事项或与该事项有关的筹划、商谈、意向、协议等， 董事会也未获悉本公司有根据《北京证券交易所股票上市规则》等有关规定应披 露而未披露的、对本公司股票交易价格产生较大影响的信息。 公司控股股东、实际控制人及一致行动人，持股 5%以上股东，在任的董事 及高级管理人员。 一、股票交易异常波动的具体情况 2、 核实方式： 公司股票最近 2 个有成交的交易日（2026 年 1 月 5 日至 2026 年 1 月 6 日） 以内收盘价涨幅偏离值累计达到 65.30%，根据《北京证券交易所交易规则（试 行》的有关规定，属于股票交易异常波动情形。 电话询问、口头询问、微信询问等方式。 二、公司关注并核实的相关情况 3 ...

Group 1 - The stock of BeiYikang (920199) reached the daily limit, with a turnover rate of 9.27% and a transaction amount of 200 million yuan [2] - The stock was listed on the North Exchange's daily limit due to a price increase of 29.98%, with a net buying amount of 2.6089 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction amount of 95.5737 million yuan, with a buying amount of 49.0913 million yuan and a selling amount of 46.4824 million yuan, resulting in a net buying of 2.6089 million yuan [2] Group 2 - The largest buying brokerage was Guotou Securities Co., Ltd. with a purchase amount of 14.6158 million yuan, while the largest selling brokerage was CITIC Construction Investment Securities Co., Ltd. with a selling amount of 15.6595 million yuan [2] - Over the past six months, the stock has appeared on the daily limit list seven times, with an average price increase of 5.86% the day after being listed and an average increase of 2.23% in the following five days [2]

Summary of Key Points Core Viewpoint The trading volume and value of stocks on the Beijing Stock Exchange (BSE) saw significant increases on January 6, with a total trading volume of 1.007 billion shares and a trading value of 26.037 billion yuan, marking an increase of 4.849 billion yuan compared to the previous trading day. The majority of stocks experienced price increases, indicating a positive market sentiment. Trading Performance - Total trading volume reached 1.007 billion shares, with a trading value of 26.037 billion yuan, an increase of 4.849 billion yuan from the previous day [1]. - Out of the tradable stocks, 264 stocks closed higher, accounting for 92.31% of the total, while only 21 stocks closed lower [1]. - Notable gainers included Guoyuan Technology, Haixi Communications, and Dapeng Industrial, with increases of 24.30%, 16.85%, and 15.90% respectively [1]. - The stocks with the highest trading value included Hengtong Technology, Tianli Composite, and Nacono, with trading values of 1.387 billion yuan, 1.107 billion yuan, and 628.275 million yuan respectively [1]. Stock Activity - A total of 68 stocks had trading volumes exceeding 100 million yuan, indicating high trading activity [1]. - The turnover rate for stocks was notably high, with 31 stocks having turnover rates exceeding 10%, and 6 stocks exceeding 20% [1]. - The stocks with the highest turnover rates included Dapeng Industrial, Jinhao Medical, and Hanxin Technology, with rates of 42.72%, 32.55%, and 25.42% respectively [1].